Efficacy and Safety of the Biosimilar Recombinant Human Parathyroid Hormone Cinnopar(®) in Postmenopausal Osteoporotic Women: A Randomized Double-blind Clinical Trial

por TABATABAEI-MALAZY, Ozra, NORANI, Masumeh, HESHMAT, Ramin, QORBANI, Mostafa, VOSOOGH, Afsaneh, AFRASHTEH, Behnaz, KAHKESHAN, Farzin, AJAMI, Arman, LARIJANI, Bagher
Publicado 2018